Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
Will Parsons, Interim Director at Texas Children’s Cancer and Hematology Center, shared a post on LinkedIn:
”We’re proud to recognize the national leadership roles of (pictured L-R) Drs. Titilope Fasipe, Jacquelyn “Jackie” Powers and Venee Tubman in advancing care for children with blood disorders.
• Dr. Titi Fasipe serves as Chair of the National Heart, Lung, and Blood Institute (NHLBI) Sickle Cell Disease Advisory Committee and leads two American Society of Hematology (ASH) initiatives focused on community engagement and quality care.
• Dr. Jackie Powers is Clinical Chair for ASH’s guidelines on pediatric iron deficiency, one of the few national efforts focused on children.
• Dr. Tubman leads ASH’s global guidelines on hydroxyurea dosing and monitoring, helping standardize care for children with chronic blood disorders around the world.
Please join us in celebrating their continued leadership and impact on the lives of children and families affected by blood disorders.
The NHLBI is part of the The National Institutes of Health and is focused on advancing research and education on the prevention and treatment of heart, lung, blood and sleep disorders.
ASH is the world’s largest professional organization dedicated to advancing the understanding, diagnosis, treatment and prevention of blood and bone marrow disorders through transformative research, innovative education, and high-quality, equitable care.
Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center are joining forces to launch the Kinder Children’s Cancer Center in 2026.”
Learn more on this initiative here.
Stay updated on the global initiatives in the World of Hematology with Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals